IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway
Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT...
Saved in:
Published in | Medical oncology (Northwood, London, England) Vol. 41; no. 6; p. 155 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
14.05.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT3/HIF-1α pathway. MicroRNA (miRNA) is non-coding small RNAs that also play an important role in tumor development. Notably, Let-7 and miR-200 families are prominently altered in EOC. However, whether IL-6 regulates the expression of Let-7 and miR-200 families through the STAT3/HIF-1α signaling to induce EMT in EOC remains poorly understood. In this study, we conducted in vitro and in vivo investigations using two EOC cell lines, SKOV3, and OVCAR3 cells. Our findings demonstrate that IL-6 down-regulates the mRNA levels of Let-7c and miR-200c while up-regulating their target genes HMGA2 and ZEB1 through the STAT3/HIF-1α signaling in EOC cells and in vivo. Additionally, to explore the regulatory role of HIF-1α on miRNAs, both exogenous HIF blockers YC-1 and endogenous high expression or inhibition of HIF-1α can be utilized. Both approaches can confirm that the downstream molecule HIF-1α inhibits the expression and function of Let-7c and miR-200c. Further mechanistic research revealed that the overexpression of Let-7c or miR-200c can reverse the malignant evolution of EOC cells induced by IL-6, including EMT, invasion, and metastasis. Consequently, our results suggest that IL-6 regulates the expression of Let-7c and miR-200c through the STAT3/HIF-1α pathway, thereby promoting EMT, invasion, and metastasis in EOC cells. |
---|---|
AbstractList | Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT3/HIF-1α pathway. MicroRNA (miRNA) is non-coding small RNAs that also play an important role in tumor development. Notably, Let-7 and miR-200 families are prominently altered in EOC. However, whether IL-6 regulates the expression of Let-7 and miR-200 families through the STAT3/HIF-1α signaling to induce EMT in EOC remains poorly understood. In this study, we conducted in vitro and in vivo investigations using two EOC cell lines, SKOV3, and OVCAR3 cells. Our findings demonstrate that IL-6 down-regulates the mRNA levels of Let-7c and miR-200c while up-regulating their target genes HMGA2 and ZEB1 through the STAT3/HIF-1α signaling in EOC cells and in vivo. Additionally, to explore the regulatory role of HIF-1α on miRNAs, both exogenous HIF blockers YC-1 and endogenous high expression or inhibition of HIF-1α can be utilized. Both approaches can confirm that the downstream molecule HIF-1α inhibits the expression and function of Let-7c and miR-200c. Further mechanistic research revealed that the overexpression of Let-7c or miR-200c can reverse the malignant evolution of EOC cells induced by IL-6, including EMT, invasion, and metastasis. Consequently, our results suggest that IL-6 regulates the expression of Let-7c and miR-200c through the STAT3/HIF-1α pathway, thereby promoting EMT, invasion, and metastasis in EOC cells. Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT3/HIF-1α pathway. MicroRNA (miRNA) is non-coding small RNAs that also play an important role in tumor development. Notably, Let-7 and miR-200 families are prominently altered in EOC. However, whether IL-6 regulates the expression of Let-7 and miR-200 families through the STAT3/HIF-1α signaling to induce EMT in EOC remains poorly understood. In this study, we conducted in vitro and in vivo investigations using two EOC cell lines, SKOV3, and OVCAR3 cells. Our findings demonstrate that IL-6 down-regulates the mRNA levels of Let-7c and miR-200c while up-regulating their target genes HMGA2 and ZEB1 through the STAT3/HIF-1α signaling in EOC cells and in vivo. Additionally, to explore the regulatory role of HIF-1α on miRNAs, both exogenous HIF blockers YC-1 and endogenous high expression or inhibition of HIF-1α can be utilized. Both approaches can confirm that the downstream molecule HIF-1α inhibits the expression and function of Let-7c and miR-200c. Further mechanistic research revealed that the overexpression of Let-7c or miR-200c can reverse the malignant evolution of EOC cells induced by IL-6, including EMT, invasion, and metastasis. Consequently, our results suggest that IL-6 regulates the expression of Let-7c and miR-200c through the STAT3/HIF-1α pathway, thereby promoting EMT, invasion, and metastasis in EOC cells.Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development. Previous studies have demonstrated that IL-6 promotes EMT, invasion, and metastasis in epithelial ovarian cancer (EOC) cells by activating the STAT3/HIF-1α pathway. MicroRNA (miRNA) is non-coding small RNAs that also play an important role in tumor development. Notably, Let-7 and miR-200 families are prominently altered in EOC. However, whether IL-6 regulates the expression of Let-7 and miR-200 families through the STAT3/HIF-1α signaling to induce EMT in EOC remains poorly understood. In this study, we conducted in vitro and in vivo investigations using two EOC cell lines, SKOV3, and OVCAR3 cells. Our findings demonstrate that IL-6 down-regulates the mRNA levels of Let-7c and miR-200c while up-regulating their target genes HMGA2 and ZEB1 through the STAT3/HIF-1α signaling in EOC cells and in vivo. Additionally, to explore the regulatory role of HIF-1α on miRNAs, both exogenous HIF blockers YC-1 and endogenous high expression or inhibition of HIF-1α can be utilized. Both approaches can confirm that the downstream molecule HIF-1α inhibits the expression and function of Let-7c and miR-200c. Further mechanistic research revealed that the overexpression of Let-7c or miR-200c can reverse the malignant evolution of EOC cells induced by IL-6, including EMT, invasion, and metastasis. Consequently, our results suggest that IL-6 regulates the expression of Let-7c and miR-200c through the STAT3/HIF-1α pathway, thereby promoting EMT, invasion, and metastasis in EOC cells. |
ArticleNumber | 155 |
Author | Guo, Qiao Yun Wang, Yue Chen, Yu Meng Yuan, Hai Ning Sun, Yang Niu, Xiu long Xue, Wen Shu Chen, Xiao Song, Jiang Nan |
Author_xml | – sequence: 1 givenname: Qiao Yun surname: Guo fullname: Guo, Qiao Yun organization: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, School of Pharmacy and Biological Technology, Tianjin Medical College – sequence: 2 givenname: Jiang Nan surname: Song fullname: Song, Jiang Nan organization: Department of Gynaecology and Obstetrics, Characteristic Medical Center of Chinese People’s Armed Police Force, Department of Gynecology and Obstetrics, Chinese People’s Liberation Army General Hospital – sequence: 3 givenname: Yu Meng surname: Chen fullname: Chen, Yu Meng organization: College of Pharmacy, China Pharmaceutical University – sequence: 4 givenname: Hai Ning surname: Yuan fullname: Yuan, Hai Ning organization: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine – sequence: 5 givenname: Wen Shu surname: Xue fullname: Xue, Wen Shu organization: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine – sequence: 6 givenname: Yang surname: Sun fullname: Sun, Yang organization: Department of Gynaecology and Obstetrics, Characteristic Medical Center of Chinese People’s Armed Police Force – sequence: 7 givenname: Xiu long surname: Niu fullname: Niu, Xiu long organization: Institute of Prevention and Treatment of Dermatosis in Alpine Environment of Plateau, Characteristic Medical Center of Chinese People’s Armed Police Force – sequence: 8 givenname: Yue surname: Wang fullname: Wang, Yue email: wangyue6806@tjutcm.edu.cn organization: School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine – sequence: 9 givenname: Xiao surname: Chen fullname: Chen, Xiao organization: Department of Gynaecology and Obstetrics, Characteristic Medical Center of Chinese People’s Armed Police Force |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38744773$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kd1qHCEYhqWkNH-9gR4UoSc9iI0_M-ochpA0C1sKzQZyJuo4u4YZ3epMyt5C76Y30muq20l_6EFB-QQfHz99j8FBiMEB8IrgdwRjcZ4JxYwiTKsyGZWIPgNHpK4bRBi5P_hrfQiOc37AmJKaNi_AIZOiqoRgR-DrYok4TG499Xp0GbqtHzeu97qH8VEnrwO0OliX4NWH1Rn04VFnH8MZ1KGFgxt1LsNnaHZwiO1e4sMaLt2IhJ0Z_wlRjC0cNylO602pDt6uLlbs_GZxjcj3b3Crx80XvTsFzzvdZ_fyqZ6Au-ur1eUNWn58v7i8WCLLKC9eLpi2vMVatOX5XW2IYZ2RjBnccWltYzpjXdtgzVqBXSekltLwWmrOqvJRJ-Dt7N2m-HlyeVSDz9b1vQ4uTlkxXNdVjUnDCvrmH_QhTimU7vZUxbkUrCoUnSmbYs7JdWqb_KDTThGs9kmpOSlVklI_k1L7Ll4_qSczuPb3kV_RFIDNQC5bYe3Sn7v_o_0BU-ufXA |
Cites_doi | 10.1002/cac2.12138 10.4161/rna.5.3.6558 10.1016/j.canlet.2015.01.010 10.3389/fphar.2016.00271 10.1016/j.lfs.2017.01.005 10.1016/S1470-2045(11)70123-1 10.4161/cbt.7.1.5458 10.1016/S1995-7645(14)60040-7 10.1016/j.biopha.2020.110037 10.1007/s13277-015-4625-2 10.1038/onc.2012.573 10.4161/cc.7.14.6324 10.1002/jcp.26116 10.1186/1471-2164-14-352 10.1016/j.molcel.2012.01.015 10.1021/pr9007927 10.1038/s41598-018-27184-9 10.3892/or.2014.3022 10.1016/j.yexcr.2017.09.014 10.4149/neo_2014_082 10.1155/2023/8334881 10.31557/APJCP.2021.22.2.407 10.1016/j.hpb.2021.06.421 10.1371/journal.pone.0023752 10.1038/modpathol.2010.49 10.1007/s00109-013-1080-7 10.1007/s00432-010-0898-4 10.1371/journal.pone.0077249 10.1126/science.1137999 10.1007/s00018-018-2941-6 10.1007/s13277-015-3138-3 10.1016/j.ejphar.2020.173817 10.1002/jcp.24593 10.1186/s12964-020-00562-5 10.1016/j.semcancer.2022.03.028 10.1038/sj.bjc.6604794 10.3390/ijms22158334 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION K9. 7X8 |
DOI | 10.1007/s12032-024-02328-2 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1559-131X |
ExternalDocumentID | 10_1007_s12032_024_02328_2 38744773 |
Genre | Journal Article |
GrantInformation_xml | – fundername: the Great Program of Science Foundation of Tianjin grantid: No. 18JCZDJC33200 – fundername: the National Natural Science Foundation of China grantid: No.81572852; 81273520 – fundername: Center Innovation Team Project grantid: KYCXTD0502; KYCXTD0203 – fundername: Center Innovation Team Project grantid: KYCXTD0203 – fundername: the National Natural Science Foundation of China grantid: 81273520 – fundername: Center Innovation Team Project grantid: KYCXTD0502 – fundername: the National Natural Science Foundation of China grantid: No.81572852 |
GroupedDBID | --- -53 -5E -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 203 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 4.4 406 408 40E 53G 5GY 5RE 5VS 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAFGU AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN ABAKF ABDZT ABECU ABFGW ABFTV ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACBMV ACBRV ACBYP ACCUX ACDTI ACGFS ACHSB ACHVE ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACTTH ACVWB ACWMK ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEFTE AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFBBN AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AIAKS AIGIU AIIXL AILAN AIMYW AITGF AJDOV AJRNO AJZVZ AKMHD AKQUC ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD B-. BA0 BENPR BGNMA CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBLON EBS EIOEI EJD ESBYG F5P FERAY FFXSO FIGPU FNLPD FRRFC FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 HF~ HG6 HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ IWAJR IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y MA- N9A NF0 NPVJJ NQJWS NU0 O93 O9G O9I O9J P19 P9S PF0 PT4 PT5 PZZ QOK QOR QOS R89 R9I RHV ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDE SDH SDM SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TSG TT1 TUC U2A U9L UG4 UNUBA UOJIU UTJUX VC2 W48 WK8 YLTOR Z7U Z82 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX AAYZH CGR CUY CVF ECM EIF NPM SJYHP AAYXX CITATION K9. 7X8 |
ID | FETCH-LOGICAL-c326t-7673ac6d0a7d032f5b1b3fb833b0f68cc9bfbced90a3d70ef78a88b658a634023 |
IEDL.DBID | U2A |
ISSN | 1559-131X 1357-0560 |
IngestDate | Sat Oct 26 04:38:58 EDT 2024 Thu Oct 10 16:56:34 EDT 2024 Thu Sep 12 18:30:49 EDT 2024 Sat Nov 02 12:29:27 EDT 2024 Sat Jun 15 09:01:22 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Let-7c and miR-200c Epithelial ovarian cancer (EOC) IL-6/STAT3/HIF-1α EMT Invasion and metastasis |
Language | English |
License | 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c326t-7673ac6d0a7d032f5b1b3fb833b0f68cc9bfbced90a3d70ef78a88b658a634023 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 38744773 |
PQID | 3054668734 |
PQPubID | 30753 |
ParticipantIDs | proquest_miscellaneous_3055450193 proquest_journals_3054668734 crossref_primary_10_1007_s12032_024_02328_2 pubmed_primary_38744773 springer_journals_10_1007_s12032_024_02328_2 |
PublicationCentury | 2000 |
PublicationDate | 2024-05-14 |
PublicationDateYYYYMMDD | 2024-05-14 |
PublicationDate_xml | – month: 05 year: 2024 text: 2024-05-14 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Middlesex |
PublicationTitle | Medical oncology (Northwood, London, England) |
PublicationTitleAbbrev | Med Oncol |
PublicationTitleAlternate | Med Oncol |
PublicationYear | 2024 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Yang, Wu (CR15) 2008; 7 Garg, Potter, Abrahams (CR35) 2013; 8 Korpal, Kang (CR41) 2008; 5 Yang, Ma, Zhou, Cao, Zhou, Zhang, Zhao, Liu, Fan (CR26) 2019; 76 Shan, Li, Huang (CR27) 2014; 229 Pan, Liu, Shang, Zhou, Yang (CR7) 2021; 41 Gyamfi, Lee, Eom, Choi (CR4) 2018; 8 Mir, Bashir, Jan (CR10) 2023 Mahajan, Liu, Gellert, Zou, Yang, Lee (CR19) 2010; 23 Xi, Xin, Ye (CR21) 2014; 7 Abaurrea, Araujo, Caffarel (CR23) 2021; 22 Shi, Li, Wu, Tang, Chen, Xue (CR20) 2016; 37 Guo, Chen, Shi, Wang, Chen, Diao (CR18) 2013; 32 Nilsson, Dillon, Devakumar, Shi, Greig, Rogers (CR37) 2010; 9 Huang, Chen, Wu, He, Huang, Liu, Wang, Wang (CR24) 2017; 171 Macciò, Madeddu (CR8) 2013; 91 Gao, Wu (CR29) 2015; 36 Zare, Bastami, Solali, Alivand (CR16) 2018; 233 Kang, Cui, Zhang, Yang, Jiang (CR28) 2013; 14 Rokavec, Wu, Luo (CR34) 2012; 45 Xu, Yu, Ma (CR6) 2021; 894 Canale, Foschi, Andreone, Ercolani, Marisi, Conti (CR32) 2022; 24 Tsai, Lin, Wang, Chiu, Chou, Chiu (CR30) 1852; 2015 Yan, Zhang, Fan, Li, Zhou (CR31) 2014; 61 Yuan (CR3) 2011; 40 Zhang, Yang, Sun, Song (CR5) 2023; 2023 Colomiere, Ward, Riley, Trenerry, Cameron-Smith, Findlay (CR11) 2009; 100 Joseph, Conroy, Pavlov, Sontakke, Tomar, Eggens-Meijer (CR14) 2015; 359 Shang, Chen, Ye, Wei, Liu, Wang (CR25) 2017; 360 Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal (CR1) 2020; 71 Kozak, Jonak, Maciejewski (CR38) 2020; 125 Mahmood, Mushtaq, Jamal, Hanif, Akhlaq, Awan (CR17) 2021; 22 Bose, Saha, Chatterjee, Srivastava (CR9) 2022; 86 Cheng, Sun, Wang, Gao, Zhang, Zhou (CR12) 2011; 6 Kim, Cassone, Otvos, Vogiatzi (CR36) 2008; 7 Cooke, Brenton (CR2) 2011; 12 Cheng, Wang, Liu, Liu, Xia, Xu (CR13) 2014; 31 Mayr, Hemann, Bartel (CR33) 2007; 315 Sulaiman, Ab Mutalib, Jamal (CR22) 2016; 7 Li, Shi, Liu (CR40) 2020; 18 Wong, Man, Tsang, Tsao, Tsang, Chan (CR39) 2011; 137 Z Shi (2328_CR20) 2016; 37 A Macciò (2328_CR8) 2013; 91 J Gyamfi (2328_CR4) 2018; 8 W Yang (2328_CR26) 2019; 76 Y Shang (2328_CR25) 2017; 360 F Shan (2328_CR27) 2014; 229 Y Yan (2328_CR31) 2014; 61 M Korpal (2328_CR41) 2008; 5 MA Mir (2328_CR10) 2023 SA Sulaiman (2328_CR22) 2016; 7 SL Cooke (2328_CR2) 2011; 12 CL Nilsson (2328_CR37) 2010; 9 N Mahmood (2328_CR17) 2021; 22 Y Gao (2328_CR29) 2015; 36 G Pan (2328_CR7) 2021; 41 M Garg (2328_CR35) 2013; 8 M Yang (2328_CR15) 2008; 7 A Mahajan (2328_CR19) 2010; 23 L Guo (2328_CR18) 2013; 32 Q Li (2328_CR40) 2020; 18 J Kozak (2328_CR38) 2020; 125 M Zare (2328_CR16) 2018; 233 CX Huang (2328_CR24) 2017; 171 T Zhang (2328_CR5) 2023; 2023 M Canale (2328_CR32) 2022; 24 H Sung (2328_CR1) 2020; 71 T Wong (2328_CR39) 2011; 137 Y Xi (2328_CR21) 2014; 7 M Colomiere (2328_CR11) 2009; 100 S Bose (2328_CR9) 2022; 86 JV Joseph (2328_CR14) 2015; 359 C Tsai (2328_CR30) 1852; 2015 Y Yuan (2328_CR3) 2011; 40 S Xu (2328_CR6) 2021; 894 Z Cheng (2328_CR13) 2014; 31 L Kang (2328_CR28) 2013; 14 M Rokavec (2328_CR34) 2012; 45 C Mayr (2328_CR33) 2007; 315 HL Kim (2328_CR36) 2008; 7 Z Cheng (2328_CR12) 2011; 6 A Abaurrea (2328_CR23) 2021; 22 |
References_xml | – volume: 41 start-page: 199 issue: 3 year: 2021 end-page: 217 ident: CR7 article-title: EMT-associated microRNAs and their roles in cancer stemness and drug resistance publication-title: Cancer Commun doi: 10.1002/cac2.12138 contributor: fullname: Yang – volume: 5 start-page: 115 issue: 3 year: 2008 end-page: 119 ident: CR41 article-title: The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis publication-title: RNA Biol doi: 10.4161/rna.5.3.6558 contributor: fullname: Kang – volume: 71 start-page: 209 issue: 2021 year: 2020 end-page: 249 ident: CR1 article-title: Global Cancer Statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: Cancer J. Clin. contributor: fullname: Jemal – start-page: 137 year: 2023 end-page: 164 ident: CR10 publication-title: The role of interleukin (IL)-6/IL-6 receptor axis in cancer, cytokine and chemokine networks in cancer contributor: fullname: Jan – volume: 359 start-page: 107 year: 2015 end-page: 116 ident: CR14 article-title: Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis publication-title: Cancer Lett doi: 10.1016/j.canlet.2015.01.010 contributor: fullname: Eggens-Meijer – volume: 7 start-page: 271 year: 2016 ident: CR22 article-title: Mir-200c regulation of metastases in ovarian cancer: potential role in epithelial and mesenchymal transition publication-title: Front. Pharmacol. doi: 10.3389/fphar.2016.00271 contributor: fullname: Jamal – volume: 171 start-page: 21 year: 2017 end-page: 29 ident: CR24 article-title: Zebrafish let-7b acts downstream of hypoxia-inducible factor-1α to assist in hypoxia-mediated cell proliferation and cell cycle regulation publication-title: Life Sci doi: 10.1016/j.lfs.2017.01.005 contributor: fullname: Wang – volume: 12 start-page: 1169 year: 2011 end-page: 1174 ident: CR2 article-title: Evolution of platinum resistance in high-grade serous ovarian cancer publication-title: Lancet Oncol doi: 10.1016/S1470-2045(11)70123-1 contributor: fullname: Brenton – volume: 7 start-page: 10 issue: 1 year: 2008 end-page: 14 ident: CR36 article-title: HIF-1α and STAT3 client proteins interacting with the cancer chaperone Hsp90: therapeutic considerations publication-title: Cancer Biol Ther doi: 10.4161/cbt.7.1.5458 contributor: fullname: Vogiatzi – volume: 7 start-page: 289 year: 2014 end-page: 292 ident: CR21 article-title: Effects of hmga2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells publication-title: Asian Pacific J Trop Med doi: 10.1016/S1995-7645(14)60040-7 contributor: fullname: Ye – volume: 125 year: 2020 ident: CR38 article-title: The function of mir-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110037 contributor: fullname: Maciejewski – volume: 37 start-page: 7515 year: 2016 end-page: 7523 ident: CR20 article-title: Silencing of hmga2 suppresses cellular proliferation, migration, invasion, and epithelial–mesenchymal transition in bladder cancer publication-title: Tumor Biology doi: 10.1007/s13277-015-4625-2 contributor: fullname: Xue – volume: 32 start-page: 5272 year: 2013 end-page: 5282 ident: CR18 article-title: Stat3-coordinated lin-28–let-7–hmga2 and mir-200–zeb1 circuits initiate and maintain oncostatin m-driven epithelial–mesenchymal transition publication-title: Oncogene doi: 10.1038/onc.2012.573 contributor: fullname: Diao – volume: 7 start-page: 2090 year: 2008 end-page: 2096 ident: CR15 article-title: Twist activation by hypoxia inducible factor-1 (hif-1): implications in metastasis and development publication-title: Cell Cycle doi: 10.4161/cc.7.14.6324 contributor: fullname: Wu – volume: 233 start-page: 3729 year: 2018 end-page: 3744 ident: CR16 article-title: Aberrant mirna promoter methylation and emt-involving mirnas in breast cancer metastasis: diagnosis and therapeutic implications publication-title: J Cell Physiol doi: 10.1002/jcp.26116 contributor: fullname: Alivand – volume: 14 start-page: 352 year: 2013 ident: CR28 article-title: Identification of microRNAs associated with sexual maturity in chicken ovary by illumina small RNA deep sequencing publication-title: BMC Genomics doi: 10.1186/1471-2164-14-352 contributor: fullname: Jiang – volume: 45 start-page: 777 year: 2012 end-page: 789 ident: CR34 article-title: IL6-mediated suppression of mir-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis publication-title: Mol Cell doi: 10.1016/j.molcel.2012.01.015 contributor: fullname: Luo – volume: 9 start-page: 430 year: 2010 end-page: 443 ident: CR37 article-title: Quantitative phosphoproteomic analysis of the stat3/il-6/hif1α signaling network: an initial study in gsc11 glioblastoma stem cells publication-title: J Proteome Res doi: 10.1021/pr9007927 contributor: fullname: Rogers – volume: 8 start-page: 8859 year: 2018 ident: CR4 article-title: Interleukin-6/stat3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells publication-title: Sci Rep doi: 10.1038/s41598-018-27184-9 contributor: fullname: Choi – volume: 31 start-page: 1891 year: 2014 end-page: 1898 ident: CR13 article-title: Effects of the hif-1α and NF-κb loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells publication-title: Oncol Rep doi: 10.3892/or.2014.3022 contributor: fullname: Xu – volume: 360 start-page: 243 year: 2017 end-page: 256 ident: CR25 article-title: Hif-1α/ascl2/mir-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2017.09.014 contributor: fullname: Wang – volume: 61 start-page: 672 year: 2014 end-page: 679 ident: CR31 article-title: Breast cancer-specific trail expression mediated by miRNA response elements of let-7 and mir-122 publication-title: Neoplasma doi: 10.4149/neo_2014_082 contributor: fullname: Zhou – volume: 2023 start-page: 1 year: 2023 end-page: 14 ident: CR5 article-title: Interleukin-6 and hypoxia synergistically promote EMT-mediated invasion in epithelial ovarian cancer via the IL-6/STAT3/HIF-1α feedback loop publication-title: Anal Cell Pathol doi: 10.1155/2023/8334881 contributor: fullname: Song – volume: 22 start-page: 407 year: 2021 ident: CR17 article-title: Potential utility of cell free high mobility group at-hook 2 (hmga2) as a prognostic biomarker in liquid biopsies of oral squamous cell carcinoma publication-title: Asian Pacific J Cancer Prev: APJCP doi: 10.31557/APJCP.2021.22.2.407 contributor: fullname: Awan – volume: 24 start-page: 244 year: 2022 end-page: 254 ident: CR32 article-title: Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery publication-title: HPB doi: 10.1016/j.hpb.2021.06.421 contributor: fullname: Conti – volume: 6 year: 2011 ident: CR12 article-title: Nuclear factor-κb–dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions publication-title: PLoS ONE doi: 10.1371/journal.pone.0023752 contributor: fullname: Zhou – volume: 23 start-page: 673 year: 2010 end-page: 681 ident: CR19 article-title: Hmga2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma publication-title: Mod Pathol doi: 10.1038/modpathol.2010.49 contributor: fullname: Lee – volume: 91 start-page: 1355 year: 2013 end-page: 1368 ident: CR8 article-title: The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications-a review publication-title: J Mol Med doi: 10.1007/s00109-013-1080-7 contributor: fullname: Madeddu – volume: 137 start-page: 415 year: 2011 end-page: 422 ident: CR39 article-title: MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through down regulating c-myc expression publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-010-0898-4 contributor: fullname: Chan – volume: 8 year: 2013 ident: CR35 article-title: Identification of microRNAs that regulate tlr2-mediated trophoblast apoptosis and inhibition of IL-6 miRNA publication-title: PLoS ONE doi: 10.1371/journal.pone.0077249 contributor: fullname: Abrahams – volume: 315 start-page: 1576 year: 2007 end-page: 1579 ident: CR33 article-title: Disrupting the pairing betweenlet-7 and hmga2 enhances oncogenic transformation publication-title: Science doi: 10.1126/science.1137999 contributor: fullname: Bartel – volume: 76 start-page: 453 issue: 3 year: 2019 end-page: 471 ident: CR26 article-title: Reciprocal regulations between miRNAs and HIF-1α in human cancers publication-title: Cell Mol Life Sci doi: 10.1007/s00018-018-2941-6 contributor: fullname: Fan – volume: 2015 start-page: 851 year: 1852 end-page: 861 ident: CR30 article-title: Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA publication-title: Biochim. Biophys. Acta Mol. Basis Dis. contributor: fullname: Chiu – volume: 36 start-page: 4843 year: 2015 end-page: 4850 ident: CR29 article-title: Microrna-200c and microrna-141 as potential diagnostic and prognostic biomarkers for ovarian cancer publication-title: Tumor Biology doi: 10.1007/s13277-015-3138-3 contributor: fullname: Wu – volume: 894 year: 2021 ident: CR6 article-title: IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2020.173817 contributor: fullname: Ma – volume: 229 start-page: 1511 issue: 10 year: 2014 end-page: 1520 ident: CR27 article-title: HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia publication-title: J Cell Physiol doi: 10.1002/jcp.24593 contributor: fullname: Huang – volume: 18 start-page: 108 year: 2020 ident: CR40 article-title: The role of wnt/β-catenin-lin28a/let-7 axis in embryo implantation competency and epithelial-mesenchymal transition (EMT) publication-title: Cell Commun Signal doi: 10.1186/s12964-020-00562-5 contributor: fullname: Liu – volume: 40 start-page: 1171 year: 2011 end-page: 1179 ident: CR3 article-title: Il-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures publication-title: Int J Oncol contributor: fullname: Yuan – volume: 86 start-page: 568 issue: Pt 2 year: 2022 end-page: 579 ident: CR9 article-title: Chemokines driven ovarian cancer progression, metastasis and chemoresistance: potential pharmacological targets for cancer therapy publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2022.03.028 contributor: fullname: Srivastava – volume: 100 start-page: 134 year: 2009 end-page: 144 ident: CR11 article-title: Cross talk of signals between EGFR and IL-6 through jak2/stat3 mediate epithelial–mesenchymal transition in ovarian carcinomas publication-title: Br J Cancer doi: 10.1038/sj.bjc.6604794 contributor: fullname: Findlay – volume: 22 start-page: 8334 issue: 15 year: 2021 ident: CR23 article-title: The role of the IL-6 cytokine family in epithelial-mesenchymal plasticity in cancer progression publication-title: Int J Mol Sci doi: 10.3390/ijms22158334 contributor: fullname: Caffarel – volume: 360 start-page: 243 year: 2017 ident: 2328_CR25 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2017.09.014 contributor: fullname: Y Shang – volume: 7 start-page: 271 year: 2016 ident: 2328_CR22 publication-title: Front. Pharmacol. doi: 10.3389/fphar.2016.00271 contributor: fullname: SA Sulaiman – volume: 41 start-page: 199 issue: 3 year: 2021 ident: 2328_CR7 publication-title: Cancer Commun doi: 10.1002/cac2.12138 contributor: fullname: G Pan – volume: 5 start-page: 115 issue: 3 year: 2008 ident: 2328_CR41 publication-title: RNA Biol doi: 10.4161/rna.5.3.6558 contributor: fullname: M Korpal – volume: 100 start-page: 134 year: 2009 ident: 2328_CR11 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6604794 contributor: fullname: M Colomiere – volume: 137 start-page: 415 year: 2011 ident: 2328_CR39 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-010-0898-4 contributor: fullname: T Wong – volume: 7 start-page: 2090 year: 2008 ident: 2328_CR15 publication-title: Cell Cycle doi: 10.4161/cc.7.14.6324 contributor: fullname: M Yang – volume: 23 start-page: 673 year: 2010 ident: 2328_CR19 publication-title: Mod Pathol doi: 10.1038/modpathol.2010.49 contributor: fullname: A Mahajan – volume: 2015 start-page: 851 year: 1852 ident: 2328_CR30 publication-title: Biochim. Biophys. Acta Mol. Basis Dis. contributor: fullname: C Tsai – volume: 76 start-page: 453 issue: 3 year: 2019 ident: 2328_CR26 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-018-2941-6 contributor: fullname: W Yang – volume: 45 start-page: 777 year: 2012 ident: 2328_CR34 publication-title: Mol Cell doi: 10.1016/j.molcel.2012.01.015 contributor: fullname: M Rokavec – volume: 359 start-page: 107 year: 2015 ident: 2328_CR14 publication-title: Cancer Lett doi: 10.1016/j.canlet.2015.01.010 contributor: fullname: JV Joseph – volume: 40 start-page: 1171 year: 2011 ident: 2328_CR3 publication-title: Int J Oncol contributor: fullname: Y Yuan – volume: 18 start-page: 108 year: 2020 ident: 2328_CR40 publication-title: Cell Commun Signal doi: 10.1186/s12964-020-00562-5 contributor: fullname: Q Li – volume: 22 start-page: 407 year: 2021 ident: 2328_CR17 publication-title: Asian Pacific J Cancer Prev: APJCP doi: 10.31557/APJCP.2021.22.2.407 contributor: fullname: N Mahmood – volume: 315 start-page: 1576 year: 2007 ident: 2328_CR33 publication-title: Science doi: 10.1126/science.1137999 contributor: fullname: C Mayr – volume: 12 start-page: 1169 year: 2011 ident: 2328_CR2 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(11)70123-1 contributor: fullname: SL Cooke – volume: 8 year: 2013 ident: 2328_CR35 publication-title: PLoS ONE doi: 10.1371/journal.pone.0077249 contributor: fullname: M Garg – volume: 37 start-page: 7515 year: 2016 ident: 2328_CR20 publication-title: Tumor Biology doi: 10.1007/s13277-015-4625-2 contributor: fullname: Z Shi – volume: 7 start-page: 289 year: 2014 ident: 2328_CR21 publication-title: Asian Pacific J Trop Med doi: 10.1016/S1995-7645(14)60040-7 contributor: fullname: Y Xi – volume: 32 start-page: 5272 year: 2013 ident: 2328_CR18 publication-title: Oncogene doi: 10.1038/onc.2012.573 contributor: fullname: L Guo – volume: 24 start-page: 244 year: 2022 ident: 2328_CR32 publication-title: HPB doi: 10.1016/j.hpb.2021.06.421 contributor: fullname: M Canale – volume: 8 start-page: 8859 year: 2018 ident: 2328_CR4 publication-title: Sci Rep doi: 10.1038/s41598-018-27184-9 contributor: fullname: J Gyamfi – volume: 171 start-page: 21 year: 2017 ident: 2328_CR24 publication-title: Life Sci doi: 10.1016/j.lfs.2017.01.005 contributor: fullname: CX Huang – volume: 125 year: 2020 ident: 2328_CR38 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2020.110037 contributor: fullname: J Kozak – volume: 71 start-page: 209 issue: 2021 year: 2020 ident: 2328_CR1 publication-title: Cancer J. Clin. contributor: fullname: H Sung – volume: 36 start-page: 4843 year: 2015 ident: 2328_CR29 publication-title: Tumor Biology doi: 10.1007/s13277-015-3138-3 contributor: fullname: Y Gao – volume: 14 start-page: 352 year: 2013 ident: 2328_CR28 publication-title: BMC Genomics doi: 10.1186/1471-2164-14-352 contributor: fullname: L Kang – volume: 86 start-page: 568 issue: Pt 2 year: 2022 ident: 2328_CR9 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2022.03.028 contributor: fullname: S Bose – volume: 6 year: 2011 ident: 2328_CR12 publication-title: PLoS ONE doi: 10.1371/journal.pone.0023752 contributor: fullname: Z Cheng – start-page: 137 volume-title: The role of interleukin (IL)-6/IL-6 receptor axis in cancer, cytokine and chemokine networks in cancer year: 2023 ident: 2328_CR10 contributor: fullname: MA Mir – volume: 7 start-page: 10 issue: 1 year: 2008 ident: 2328_CR36 publication-title: Cancer Biol Ther doi: 10.4161/cbt.7.1.5458 contributor: fullname: HL Kim – volume: 31 start-page: 1891 year: 2014 ident: 2328_CR13 publication-title: Oncol Rep doi: 10.3892/or.2014.3022 contributor: fullname: Z Cheng – volume: 9 start-page: 430 year: 2010 ident: 2328_CR37 publication-title: J Proteome Res doi: 10.1021/pr9007927 contributor: fullname: CL Nilsson – volume: 894 year: 2021 ident: 2328_CR6 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2020.173817 contributor: fullname: S Xu – volume: 233 start-page: 3729 year: 2018 ident: 2328_CR16 publication-title: J Cell Physiol doi: 10.1002/jcp.26116 contributor: fullname: M Zare – volume: 61 start-page: 672 year: 2014 ident: 2328_CR31 publication-title: Neoplasma doi: 10.4149/neo_2014_082 contributor: fullname: Y Yan – volume: 229 start-page: 1511 issue: 10 year: 2014 ident: 2328_CR27 publication-title: J Cell Physiol doi: 10.1002/jcp.24593 contributor: fullname: F Shan – volume: 2023 start-page: 1 year: 2023 ident: 2328_CR5 publication-title: Anal Cell Pathol doi: 10.1155/2023/8334881 contributor: fullname: T Zhang – volume: 91 start-page: 1355 year: 2013 ident: 2328_CR8 publication-title: J Mol Med doi: 10.1007/s00109-013-1080-7 contributor: fullname: A Macciò – volume: 22 start-page: 8334 issue: 15 year: 2021 ident: 2328_CR23 publication-title: Int J Mol Sci doi: 10.3390/ijms22158334 contributor: fullname: A Abaurrea |
SSID | ssj0021529 |
Score | 2.420198 |
Snippet | Interleukin-6 (IL-6) and hypoxia-inducible factor-1α (HIF-1α) play important roles in epithelial-mesenchymal transformation (EMT) and tumor development.... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 155 |
SubjectTerms | Animals Carcinoma, Ovarian Epithelial - genetics Carcinoma, Ovarian Epithelial - metabolism Carcinoma, Ovarian Epithelial - pathology Cell Line, Tumor Epithelial-Mesenchymal Transition - genetics Female Gene Expression Regulation, Neoplastic Hematology Humans Hypoxia-Inducible Factor 1, alpha Subunit - genetics Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Interleukin-6 - genetics Interleukin-6 - metabolism Internal Medicine Medicine Medicine & Public Health Metastasis Mice Mice, Inbred BALB C Mice, Nude MicroRNAs MicroRNAs - genetics Neoplasm Invasiveness - genetics Neoplasm Metastasis Neoplasms, Glandular and Epithelial - genetics Neoplasms, Glandular and Epithelial - metabolism Neoplasms, Glandular and Epithelial - pathology Oncology Original Paper Ovarian cancer Ovarian Neoplasms - genetics Ovarian Neoplasms - metabolism Ovarian Neoplasms - pathology Pathology Signal Transduction STAT3 Transcription Factor - genetics STAT3 Transcription Factor - metabolism |
Title | IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway |
URI | https://link.springer.com/article/10.1007/s12032-024-02328-2 https://www.ncbi.nlm.nih.gov/pubmed/38744773 https://www.proquest.com/docview/3054668734 https://www.proquest.com/docview/3055450193 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NTuMwELb4kVZcVruwu3SXRUbiRq1NM7GdHCvUbvk9QCuxp8h_QZUgRW0B8Qq8DS_CMzF20lYr4MAhysETJ_I38Xz2eGYI2Y1bSRG8upGyGUugiFkWxY6hpbHCZT4DeDhtcSp6g-Twgl8s4rjDYfeZRzJM1ItYN1_rm6FJwQtihHeZrHKfDg2VeBC356ssNEhZHR3z9nP_W6BXtPKVSzRYmu4X8rmmiLRdYfqVLLlynXw6qZ3gG-Tx4JgJOq6KyLsJdTc-ruIKFYmO7nDpq0pqPJZj2jnpN-mwvFN-S6xJVWnptZsqJIST4YTqB3o9sqF8V3lJj92USVPJDM-8WhtaF_HBu6Pn_XYf_vQOuqz1_ER9IeN79fCNDLqd_n6P1SUVmEGehv0ICcoIGylpcVgKrlsaCp0C6KgQqTGZLrRxNosUWBm5QqYqTTXSFCUAl5rwnayUo9JtEirB8diA5dy6BCBSxiUcCm44T41VcYPszYY5v6kyZ-SLHMkelBxByQMoOUpvzZDI679okuNclAiRSkgaZGfejPrvnRqqdKPbIIMkEIkqNMiPCsH568Dn9pcSW5ozSBedv_8tPz8m_ousxUG9OGslW2RlOr51v5GpTPU2WW3__XfU2Q4a-gKCXd-4 |
link.rule.ids | 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fb9MwELdgSLAXBAO2jgGexBu1SHOxnTxWaFUL7R62VNpb5H9BlVg6Nd2mfYV9G74In4mzk7RCgwceojz44kT-nX0_53x3hHyMB0kZvLqRshlLoIxZFsWOoaWxwmU-A3g4bXEqxvPk6wW_aIPC6u60e-eSDCv1NtjNF_tmaFPwghjxfUye-PzqPmP-PB5utllokbI2PObvz_1pgh7wygc-0WBqRi_I85Yj0mED6kvyyFV75Oms9YK_IveTKRN01VSRdzV1Vz6w4gdqEl3e4N5XVdR4MFf0ZJb36aK6Uf6fWJ-qytJLt1bICOtFTfUdvVzaUL-r-k6nbs2kaWQWZ16vDW2r-ODd0fN8mMPn8WTEBr9-Ul_J-FbdvSbz0Un-ZczamgrMIFHDfoQEZYSNlLQ4LCXXAw2lTgF0VIrUmEyX2jibRQqsjFwpU5WmGnmKEoB7TXhDdqpl5Q4IleB4bMBybl0CECnjEg4lN5ynxqq4Rz51w1xcNakzim2SZA9KgaAUAZQCpY86JIp2GtUFLkaJEKmEpEeON804AbxXQ1VueR1kkAUiU4Ue2W8Q3LwOfHJ_KbGl30G67fzf33L4f-IfyLNxPpsW08npt7dkNw6qxtkgOSI769W1e4e0Za3fBy39DWoJ4X8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELagK6248GYpLGAkbtTbNH4kOVbQ0rLdFYKutJwiP1EF61Ztumj5Cfwb_gi_iXEeLbBwQByiHDxxbM9M5nPGM4PQs7jHXOnVjaTJCKMuJlkUWwKWxgibhQzg5WmLYzE6Ya9P-elPUfzlaffGJVnFNIQsTb7oLozrbgPfQuFvAvYFLhoDr6-iHRYyI7XQTv_V-8PBZtMF9imrg2X-_OSvBukSyrzkIS0Nz_AGks2Qq_MmHw_WhTrQX37L5vg_c7qJrteoFPcrMbqFrlh_G-0e1X73O-jreEIEXlZ16-0K20UI5fgEsovn57Dblh7rID5LPDiadvDMn8vwF66DpTf4zBYSMOhqtsLqAp_NTVkxzH_AE1uQRFc0s7dBkzSu6wbB3eJ30_6UdkfjIel9_4ZD7eTP8uIuOhkOpi9GpK7iQDRAQ-hHJFRqYSKZGJig46qnqFMppSpyItU6U05pa7JIUpNE1iWpTFMFyEgKCrtbeg-1_Nzb-wgn1PJYU8O5sYzSSGrLOHVcc55qI-M2et6wMl9UyTrybVrmsLw5LG9eLm8O1PsNt_NacVc5fP6YEGlCWRs93TSDygU_ivR2vi5pAHcCNqZttFdJyeZ1NJQTSBJo6TQc33b-97E8-DfyJ2j3zcthPhkfHz5E1-JSZjjpsX3UKpZr-whwUqEe16rwA2iuB1k |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-6+regulates+epithelial+ovarian+cancer+EMT%2C+invasion%2C+and+metastasis+by+modulating+Let-7c+and+miR-200c+through+the+STAT3%2FHIF-1%CE%B1+pathway&rft.jtitle=Medical+oncology+%28Northwood%2C+London%2C+England%29&rft.au=Guo%2C+Qiao+Yun&rft.au=Song%2C+Jiang+Nan&rft.au=Chen%2C+Yu+Meng&rft.au=Yuan%2C+Hai+Ning&rft.date=2024-05-14&rft.pub=Springer+US&rft.eissn=1559-131X&rft.volume=41&rft.issue=6&rft_id=info:doi/10.1007%2Fs12032-024-02328-2&rft.externalDocID=10_1007_s12032_024_02328_2 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1559-131X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1559-131X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1559-131X&client=summon |